These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 23286275)

  • 1. Benign prostatic hyperplasia is a significant risk factor for bladder cancer in diabetic patients: a population-based cohort study using the National Health Insurance in Taiwan.
    Tseng CH
    BMC Cancer; 2013 Jan; 13():7. PubMed ID: 23286275
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human insulin does not increase bladder cancer risk.
    Tseng CH
    PLoS One; 2014; 9(1):e86517. PubMed ID: 24466131
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of benign prostatic hyperplasia and subsequent risk of bladder cancer: an Asian population cohort study.
    Fang CW; Liao CH; Wu SC; Muo CH
    World J Urol; 2018 Jun; 36(6):931-938. PubMed ID: 29427001
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rosiglitazone is not associated with an increased risk of bladder cancer.
    Tseng CH
    Cancer Epidemiol; 2013 Aug; 37(4):385-9. PubMed ID: 23619142
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hyperlipidemia is associated with an increased risk of clinical benign prostatic hyperplasia.
    Shih HJ; Huang CJ; Lin JA; Kao MC; Fan YC; Tsai PS
    Prostate; 2018 Feb; 78(2):113-120. PubMed ID: 29119583
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metformin may reduce bladder cancer risk in Taiwanese patients with type 2 diabetes.
    Tseng CH
    Acta Diabetol; 2014 Apr; 51(2):295-303. PubMed ID: 24509842
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prolonged use of human insulin increases breast cancer risk in Taiwanese women with type 2 diabetes.
    Tseng CH
    BMC Cancer; 2015 Nov; 15():846. PubMed ID: 26537234
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metformin reduces prostate cancer risk among men with benign prostatic hyperplasia: A nationwide population-based cohort study.
    Kuo YJ; Sung FC; Hsieh PF; Chang HP; Wu KL; Wu HC
    Cancer Med; 2019 May; 8(5):2514-2523. PubMed ID: 30968600
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metformin significantly reduces incident prostate cancer risk in Taiwanese men with type 2 diabetes mellitus.
    Tseng CH
    Eur J Cancer; 2014 Nov; 50(16):2831-7. PubMed ID: 25201464
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metformin reduces thyroid cancer risk in Taiwanese patients with type 2 diabetes.
    Tseng CH
    PLoS One; 2014; 9(10):e109852. PubMed ID: 25303400
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hyperthyroidism is not a significant risk of benign prostatic hyperplasia: A nationwide population-based study.
    Man KM; Chen KB; Chen HY; Chiang JH; Su YC; Man SS; Xie DD; Wang Y; Zhang ZQ; Bi LK; Zhang T; Yu DX; Chen WC
    Medicine (Baltimore); 2018 Sep; 97(39):e12459. PubMed ID: 30278528
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rosiglitazone reduces breast cancer risk in Taiwanese female patients with type 2 diabetes mellitus.
    Tseng CH
    Oncotarget; 2017 Jan; 8(2):3042-3048. PubMed ID: 27936468
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metformin reduces ovarian cancer risk in Taiwanese women with type 2 diabetes mellitus.
    Tseng CH
    Diabetes Metab Res Rev; 2015 Sep; 31(6):619-26. PubMed ID: 25820555
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pioglitazone and oral cancer risk in patients with type 2 diabetes.
    Tseng CH
    Oral Oncol; 2014 Feb; 50(2):98-103. PubMed ID: 24239280
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of metformin and risk of kidney cancer in patients with type 2 diabetes.
    Tseng CH
    Eur J Cancer; 2016 Jan; 52():19-25. PubMed ID: 26630530
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Benign prostatic hyperplasia and subsequent risk of bladder cancer.
    Kang D; Chokkalingam AP; Gridley G; Nyren O; Johansson JE; Adami HO; Silverman D; Hsing AW
    Br J Cancer; 2007 May; 96(9):1475-9. PubMed ID: 17473820
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Type 2 diabetes increases and metformin reduces total, colorectal, liver and pancreatic cancer incidences in Taiwanese: a representative population prospective cohort study of 800,000 individuals.
    Lee MS; Hsu CC; Wahlqvist ML; Tsai HN; Chang YH; Huang YC
    BMC Cancer; 2011 Jan; 11():20. PubMed ID: 21241523
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metformin and endometrial cancer risk in Chinese women with type 2 diabetes mellitus in Taiwan.
    Tseng CH
    Gynecol Oncol; 2015 Jul; 138(1):147-53. PubMed ID: 25913129
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pioglitazone does not affect the risk of ovarian cancer: analysis of a nationwide reimbursement database in Taiwan.
    Tseng CH
    Gynecol Oncol; 2013 Oct; 131(1):135-9. PubMed ID: 23877016
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Re: benign prostatic hyperplasia is a significant risk factor for bladder cancer in diabetic patients: a population-based cohort study using the national health insurance in Taiwan.
    Kaplan SA
    J Urol; 2014 Jan; 191(1):58-9. PubMed ID: 24331477
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.